Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-08-29

FDA Approved: INBRIJA — Supplemental Application (Merz Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved a supplemental application for INBRIJA (levodopa) from Merz Pharmaceuticals, LLC. The action updates the approved product, such as labeling cha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INBRIJA (levodopa inhalation powder)

Snippet

SUPPL AP for INBRIJA (LEVODOPA)